Is a complete FBRX research report available?

No complete published report is available for Forte Biosciences, Inc. (FBRX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Forte Biosciences, Inc. (FBRX)

NASDAQ: FBRX · USD

$76.5

-0.12 (-0.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FBRX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.9B
Net income (ttm)	-75.9M
EPS (ttm)	-$4.65
Shares out	24.4M
Volume	7,249,879
Beta	2.84
Price target	$73.8	-3.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -75.9M
EPS (ttm): -$4.65
Market cap: 1.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All FBRX indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001419041
Company name	Forte Biosciences, Inc.
Country	United States
Country code	US
Cusip	34962G208
Employees	22
Employees Change	3%
Employees Change Percent	15.79
Enterprise value	$1.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US34962G2084
Last refreshed	2026-07-30
Market cap	$1.9B
Market cap category	Small-Cap
Price	$76.53
Price currency	USD
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	FBRX
Website	https://www.fortebiorx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.05%
FCF yield	-3.17%
P/B ratio	32.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-75.9M
Net Income Growth Years	0%
Profit Per Employee	$-3.4M
ROA	-83.9
Roa5y	-40.58
ROCE	-176.6
ROE	-188.4
Roe5y	-73.15
ROIC	-119.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	558.89%
Cagr3y	44.71%
Cagr5y	-37.1%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$67.2M
Cash	$58.2M
Current Assets	$65.1M
Current Liabilities	$23.6M
Debt	$0
Equity	$42.1M
Liabilities	$25.1M
Long Term Assets	$2.1M
Long Term Liabilities	$1.5M
Net Cash	$58.2M
Net Cash By Market Cap	$3.11
Net Cash Growth	26.97%
Net Debt Equity	$-1.38
Tangible Book Value	$42.1M
Tangible Book Value Per Share	$2.36
WACC	19.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.75
Net Working Capital	$-16.8M
Quick ratio	2.49
Working Capital	$41.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-207.78%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	558.04%
200-day SMA	25.79
3Y total return	203.09%
50-day SMA	29.57
50-day SMA vs 200-day SMA	50over200
5Y total return	-90.15%
All Time High	1,349.8
All Time High Change	-94.33%
All Time High Date	2020-09-24
All Time Low	4.11
All Time Low Change	1,762.04%
All Time Low Date	2024-11-01
ATR	5.14
Beta	2.84
Beta1y	0.8
Beta2y	1.78
Ch YTD	180.6
High	76.64
High52	76.68
High52 Date	2026-07-28
High52ch	-0.2%
Low	76.5
Low52	9.1
Low52 Date	2025-08-06
Low52ch	740.99%
Ma50ch	158.79%
Premarket Change Percent	0.13
Premarket Price	$76.75
Premarket Volume	391
Price vs 200-day SMA	196.72%
RSI	85.41
RSI Monthly	69.88
RSI Weekly	81.05
Sharpe ratio	1.97x
Sortino ratio	4.69
Total Return	-207.78%
Tr YTD	180.6
Tr1m	263.91%
Tr1w	35.14%
Tr3m	190.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	4
Analyst Price Target Top	$76.5
Analyst Ratings	Hold
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-1.02
Operating Income	$-77M
Price target	$73.8
Price Target Change	$-3.57
Price Target Change Top	$-0.04

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,828,202%
Float Percent	77.02%
Shares Insiders	1.81%
Shares Institutions	65.88%
Shares Out	24,446,835
Shares Qo Q	-0.14%
Shares Yo Y	207.78%
Short Float	10.94%
Short Ratio	2.43
Short Shares	8.43

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-67.2M
Adjusted OCF	-67,150,000
Average Volume	2,192,804.7x
Bv Per Share	2.36
CAPEX	$-55,000
Ch1m	263.9
Ch1w	35.14
Ch1y	558
Ch3m	190.1
Ch3y	203.1
Ch5y	-90.15
Ch6m	156.4
Change	-0.16%
Change From Open	-0.1
Close	76.65
Days Gap	-0.05
Depreciation Amortization	70,000
Dollar Volume	554,833,239.9
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-77M
EBITDA	$-76.9M
EPS	$-4.65
F Score	1
FCF	$-59.4M
FCF EV Yield	-3.28x
FCF Per Share	$-2.43
Financing CF	71,757,000
Fiscal Year End	December
Income Tax	$1.4M
Investing CF	-55,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Date	2024-08-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	28.86
Ma150ch	165.19%
Ma20	45.52
Ma20ch	68.12%
Net CF	12,367,000
Next Earnings Date	2026-08-13
Open	76.61
Optionable	Yes
Position In Range	21.43
Post Close	76.53
Postmarket Change Percent	-0.04
Postmarket Price	$76.5
Ppne	110,000
Pre Close	76.65
Price Date	2026-07-29
Ptbv Ratio	44.44
Relative Volume	3.31x
Share Based Comp	7,815,000
Tr6m	156.38%
Us State	Texas
Volume	7,249,879

Forte Biosciences, Inc. (FBRX)

Coverage state: Market snapshot only — no published research

Generate the first FBRX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · FBRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FBRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FBRX

Frequently asked questions